Mark A. King

2.2k citations
35 papers · 1.6k · 1 hit paper · h-index 15

Impact in

Papers in

Mark A. King

35 papers receiving 1.6k citations

Mark A. King's Hit Papers

Phase II Trial of Sorafenib in Metastatic Thyroid Cancer 2009 · 443 citations
4430+5+11Years since publication100200300400

Peers

Mark A. King
Comparison fields: 5 of 94
  • Psychiatry and Mental health 425
  • Endocrinology, Diabetes and Metabolism 355
  • Emergency Medicine 96
  • Pediatrics, Perinatology and Child Health 177
  • Epidemiology 286
Replace Richard B. Noto with:
Richard B. Noto United States
Sobhan Vinjamuri United Kingdom
Nat Lenzo Australia
I‐Jun Chou Taiwan
Z Braf Israel
Soo‐Nyung Kim South Korea
Hugh R. Butt United States
A Oliaro Italy
Florian Masuhr Germany
Alessandro Neri Italy
Mark A. King relative to Richard B. Noto United States Richard B. Noto's profile →
Citations per field
00.5×5×10×12.6×
Richard B. Noto · 1×
Citations per year

Countries citing papers authored by Mark A. King

Since Specialization
Citations

This map shows the geographic impact of Mark A. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. King more than expected).

Fields of papers citing papers by Mark A. King

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. King. The network helps show where Mark A. King may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark A. King, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark A. King Line = papers co-authored together Mark A. King links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1998456
2
Phase II Trial of Sorafenib in Metastatic Thyroid Cancer
Hit paper breakdown →
2009443
3 2000261
4 201565
5 201150
6 199947
7 200340
8 201532
9 200221
10 200119
11 199118
12 200417
13 200316
14 199616
15 199214
16 201212
17 201411
18 199410
19 199910
20 20049

About Mark A. King

Mark A. King is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Epidemiology, Psychiatry and Mental health and Cardiology and Cardiovascular Medicine, having authored 35 papers that have together received 1.6k indexed citations. Recurring topics across this work include Pneumocystis jirovecii pneumonia detection and treatment (5 papers), Epilepsy research and treatment (5 papers), Pleural and Pulmonary Diseases (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Metabolism and Genetic Disorders (2 papers), Cardiac tumors and thrombi (2 papers), Cardiac Structural Anomalies and Repair (2 papers) and Myasthenia Gravis and Thymoma (2 papers). The work is most often cited by research in Psychiatry and Mental health (425 citations), Endocrinology, Diabetes and Metabolism (355 citations), Emergency Medicine (96 citations), Pediatrics, Perinatology and Child Health (177 citations) and Epidemiology (286 citations). Mark A. King has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Mark R. Newton, Samuel F. Berkovic, Lex A. Mitchell, Graeme D. Jackson, Mervyn J. Silvapulle, Gregory J. Fitt, Mark D. Wewers, Thomas L. Clanton, Philip T. Diaz and Haikady N. Nagaraja. Their work appears in journals such as Academic Radiology, Journal of Thoracic Imaging, Epilepsia, CHEST Journal and The Medical Journal of Australia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact